The Baltimore riots are all over the net and MSmedia. So, I thought I’d post something a little more encouraging. Will Big Pharma and her media whores slam Iran’s cancer cure as quackery, like they do with all natural cures? Will they even discuss it? Most likely there will be a MSmedia blackout on this cure/story.(r.a. intro)
PRESS TV Posted Tues., Apr.28, 2015
Iranian researchers have produced a nano-drug which has proven effective in battling treatment resistant cancers.
The Cancer Research Center of Tehran University of Medical Sciences produced the polymer-based nanocarrier for the targeted release of the anti-cancer drug curcumin, ISNA reported on Sunday.
“This nanocarrier was made without the use of poisonous catalysts and has proven successful in clinical trials on a number of cancer patients,” said Dr Ali Mohammad Alizadeh from the Iran Nanotechnology Initiative Council.
Research has proven that curcumin, which is found in turmeric, has anti-cancer and cancer preventing properties apart from its anti-oxidant and anti-inflammatory properties, he added.
When curcumin is prescribed in its edible form, it has a low effect on the targeted tissues because of its low absorption rate and fast metabolism which causes it to be flushed from the body, he noted.
However, by capsuling curcumin in nano-emulsions (nano curcumin) its medical properties increase, Alizadeh noted.
Even if prescribed in high dosages, the drug is proven not poisonous during first-stage clinical trials and is currently near the end of stage two clinical trials on drug-resistant breast and digestive tract cancers.
Alizadeh added that because all the basic materials required to manufacture nano-curcumin are available in the country it can be domestically mass-produced as an anti-cancer drug.
UPDATE: Apr.28, 2015 Iran Reduces Side Effects Of Big Pharma’s Cancer Drug
Iranian scientists have successfully reduced the side effects of a cancer drug by infusing it with nanotechnology.
Researchers at the Tabriz University of Medical Sciences discovered that the side effects of the drug Mitoxantrone (also known as Novatrone) could be reduced when the chemotherapeutic agent is infused with liposomic nanocarriers, which are created with cholesterol derivatives, IRNA reported on Tuesday.
Mitoxantrone is a cancer drug which disrupts DNA synthesis and DNA repair in both healthy cells and cancer cells, and is used to treat certain types of cancer such as metastatic breast cancer, acute myeloid leukemia, and non-Hodgkin’s lymphoma.
The produced “nanoliposomes,” apart from being stable to pH changes in blood plasma, have proven to be more poisonous to cancer cells than to normal cells, which would reduce the required dosage and side effects, said head of the research team Dr. Saeed Qanbarzadeh.
The most common side effects of Mitoxantrone, which hinder its wider spread use, are nausea, vomiting, hair loss, heart damage, and immunosuppression.